Cytokinetics Inc - Company Profile
Powered by 
All the data and insights you need on Cytokinetics Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Cytokinetics Inc Strategy Report
- Understand Cytokinetics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Cytokinetics Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| EP4032877A1 | Application | TETRAHYDROISOCHINOLINDERIVATE | A61K31/47; A61P11/00; A61P13/00; A61P13/12; A61P21/00; A61P21/04; A61P3/04; A61P35/00; A61P9/00; A61P9/04; C07D217/24; C07D217/26; C07D471/04; C07D471/10; C07D491/107; C07D491/20; C12N2509/00; C12N2509/10; C12N5/0658 | July 27, 2022 |
| CN114765954A | Application | 心脏肌节抑制剂口服制剂 | A61K31/4178; A61K31/4245; A61K9/1623; A61K9/1652; A61K9/2018; A61K9/2054; A61K9/28; A61P9/04 | July 19, 2022 |
| WO2022140290A1 | Application | PYRAZOLE DERIVATIVES USEFUL AS NAMPT MODULATORS | A61P35/00; C07D401/14; C07D403/12; C07D403/14; C07D405/14; C07D409/14; C07D413/14; C07D417/14; C07D487/10 | June 30, 2022 |
| CN114667283A | Application | (R)-N-(5-(5-异丙基-1,2,4-噁二唑-3-基)-2,3-二氢-1H-茚-1-基)-2-甲基-2H-四唑-5-甲酰胺的多晶型物 | A61K31/4245; A61P9/04; C07B2200/13; C07D413/12 | June 24, 2022 |
| KR1020220082803A | Application | (R)-N--2,3-디하이드로-1H-인덴-1-일)-2-메틸-2H-테트라졸-5-카르복사미드의 다형체들 | A61K31/4245; A61P9/04; C07B2200/13; C07D413/12 | June 17, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer